- Home
- RFL vs VCIG Comparison
RFL vs VCIG Comparison
Compare RFL & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFL
- VCIG
- Stock Information
- Founded
- RFL 2017
- VCIG 2013
- Country
- RFL United States
- VCIG Malaysia
- Employees
- RFL N/A
- VCIG N/A
- Industry
- RFL Real Estate
- VCIG Diversified Commercial Services
- Sector
- RFL Finance
- VCIG Consumer Discretionary
- Exchange
- RFL Nasdaq
- VCIG Nasdaq
- Market Cap
- RFL 48.4M
- VCIG 15.4M
- IPO Year
- RFL N/A
- VCIG 2023
- Fundamental
- Price
- RFL $1.87
- VCIG $0.10
- Analyst Decision
- RFL
- VCIG
- Analyst Count
- RFL 0
- VCIG 0
- Target Price
- RFL N/A
- VCIG N/A
- AVG Volume (30 Days)
- RFL 58.1K
- VCIG 8.6M
- Earning Date
- RFL 12-12-2024
- VCIG 11-10-2024
- Dividend Yield
- RFL N/A
- VCIG 10.14%
- EPS Growth
- RFL N/A
- VCIG N/A
- EPS
- RFL N/A
- VCIG 0.16
- Revenue
- RFL $540,000.00
- VCIG $23,548,256.00
- Revenue This Year
- RFL N/A
- VCIG N/A
- Revenue Next Year
- RFL N/A
- VCIG N/A
- P/E Ratio
- RFL N/A
- VCIG $0.60
- Revenue Growth
- RFL 92.86
- VCIG 89.38
- 52 Week Low
- RFL $1.29
- VCIG $0.08
- 52 Week High
- RFL $2.50
- VCIG $3.71
- Technical
- Relative Strength Index (RSI)
- RFL 43.35
- VCIG 38.34
- Support Level
- RFL $1.86
- VCIG $0.08
- Resistance Level
- RFL $2.50
- VCIG $0.11
- Average True Range (ATR)
- RFL 0.12
- VCIG 0.02
- MACD
- RFL -0.05
- VCIG -0.00
- Stochastic Oscillator
- RFL 4.30
- VCIG 31.85
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.